Jn Bidco Company Profile
✉ Email this page to a colleague
What is the competitive landscape for JN BIDCO, and when can generic versions of JN BIDCO drugs launch?
JN BIDCO has one approved drug.
There are six US patents protecting JN BIDCO drugs.
There are sixty-four patent family members on JN BIDCO drugs in sixteen countries.
Drugs and US Patents for Jn Bidco
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jn Bidco | TRUDHESA | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 213436-001 | Sep 2, 2021 | RX | Yes | Yes | 9,919,117 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Jn Bidco | TRUDHESA | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 213436-001 | Sep 2, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Jn Bidco | TRUDHESA | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 213436-001 | Sep 2, 2021 | RX | Yes | Yes | 10,507,295 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Jn Bidco | TRUDHESA | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 213436-001 | Sep 2, 2021 | RX | Yes | Yes | 11,266,799 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Jn Bidco Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2017189676 | ⤷ Sign Up |
Japan | 7317020 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2012119153 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2012154859 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.